{"schema_version":"secwatch.filing_event.v1","accession":"0001104659-24-064883","form_type":"8-K","ticker":"TLSI","cik":"0001826667","company_name":"TriSalus Life Sciences, Inc.","filed_at":"2024-05-24T23:59:59+00:00","discovered_at":"2026-05-14T18:03:20.449147+00:00","generated_at":"2026-06-01T08:49:50.142361+00:00","sec_items":["8.01","9.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.65,"calibrated_materiality_score":0.65,"confidence":"high","headline":"TriSalus launches warrant exchange offer at 0.3 shares per warrant; seeks to reduce dilution","bullets":["Offering up to 4,264,532 common shares for up to 14.2M warrants (0.30 per warrant).","34.8% of Public Warrants pre-committed; needs ~15.3% more to meet majority threshold.","Consent solicitation seeks amendment allowing forced conversion at 0.27 shares (10% discount).","Expiration date: June 25, 2024; Oppenheimer & Co. is dealer manager.","Company aims to simplify capital structure and reduce future dilutive impact of warrants."],"urls":{"canonical":"https://secwatch.observer/filing/0001104659-24-064883","json":"https://secwatch.observer/filing/0001104659-24-064883.json","markdown":"https://secwatch.observer/filing/0001104659-24-064883.md","text":"https://secwatch.observer/filing/0001104659-24-064883.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1826667/000110465924064883/0001104659-24-064883-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1826667/000110465924064883/tm2415396d1_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-01T08:49:50.142361+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}